Learn · Genome Editing And Engineering
Lecture 37 of 49Week 9: Genome engineered Disease modelling
Lec 4: iPSc models - Part B
Prof. Utpal Bora · IIT Guwahati
Credits and licence
- From
- Genome Editing And Engineering, IIT Guwahati (at NPTEL)
- Licence
- CC BY-NC-SA, as NPTEL states it. Non-commercial use only.
- Attribution
- NPTEL states: "Distributed under Creative Commons Attribution-ShareAlike / CC BY - NC - SA", beside a BY-NC-SA badge.
- Who can watch
- Teens profiles and older. How courses are placed
All the lectures
- Lec 1: Introduction :Genes and Genome Organization
- Lec 2: History and Basics of Genetic Engineering
- Lec 3: Advantages and Limitations of Genetic Engineering
- Lec 1: Breakage of Genomic DNA
- Lec 2: Repair of Genomic DNA
- Lec 1: Homologous and non homologous recombination
- Lec 2: Site specific recombination
- Lec 1: Targeted genetic modification - I
- Lec 2: Targeted genetic modification - II
- Lec 1: Basics of Zinc Finger Nucleases
- Lec 2: Design of Zinc Finger Nucleases for genome editing
- Lec 3: Applications of Zinc Finger Nucleases - PART A
- Lec 4: Applications of Zinc Finger Nucleases - PART B
- Lec 1: Basics of TALEN - PART A
- Lec 2: Basics of TALEN - PART B
- Lec 3: Design of TALEN for genome editing - PART A
- Lec 4: Design of TALEN for genome editing - PART B
- Lec 5: Application of TALEN - Part A
- Lec 6: Application of TALEN - Part B
- Lec 1: CRISPR system in bacteria - Part A
- Lec 2: CRISPR system in bacteria - Part B
- Lec 3: CRISPR/Cas9 in Genome Editing - Part A
- Lec 4: CRISPR/Cas9 in Genome Editing - Part B
- Lec 5: Applications of CRISPR/Cas9 Part A
- Lec 6: Applications of CRISPR/Cas9 Part B
- Lec 7: Computational Resources for CRISPR / Cas - Part A
- Lec 8: Computational Resources for CRISPR / Cas - Part B
- Lec 1: Human cell engineering in diseases : Thalassemia - Part A
- Lec 2: Human cell engineering in diseases : Thalassemia - Part B
- Lec 3: Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part A
- Lec 4: Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part B
- Lec 5: Human cell engineering in diseases : Hemophilia - Part A
- Lec 6: Human cell engineering in diseases : Hemophilia - Part B
- Lec 1: Animal models - Part A
- Lec 2: Animal models - Part B
- Lec 3: iPSc models - Part A
- Lec 4: iPSc models - Part B
- Lec 5: Cancer disease models - Part A
- Lec 6: Cancer disease models - Part B
- Lec 1: Engineered immune cells for Cancer therapy (I) - Part A
- Lec 2: Engineered immune cells for Cancer therapy (I) - Part B
- Lec 3: Engineered immune cells for Cancer therapy (II) - Part A
- Lec 4: Engineered immune cells for Cancer therapy (II) - Part B
- Lec 1: History and Basics - Part A
- Lec 2: History and Basics - Part B
- Lec 3: Genome editing and personalized therapy
- Lec 1: Bioethics and Biosafety - Part A
- Lec 2: Bioethics and Biosafety - Part B
- Lec 3: Regulatory issues in Genome Editing